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TNF membrane receptors are usually co-expressed in many tissues but their relative contribution to cellular TNF 
responses is for most situations unknown. In a TNF cytotoxicity model of KYM·l, a human rhabdomyosarcoma cell 
line, we recently demonstrated that each of the two TNFRs is on its own capable of inducing cell death. Here we 
show that both receptors are able to induce apoptosis, as revealed (rom a similar onset of DNA fragmentation and 
typical morphologic criteria. To obtain additiona l information about the signa ling pathways involved in TRoO· and 
TR80· induced programmed cell death, we have used a series of selective inhibitors of intracellular signaling 
molecules. The overall pattern emerging from these experiments provides strong evidence for distinct signal 
pathway usage of TR60 and TR80, indicating protein kinase(s)·mediated control of TR60 signaling and a tight 
linkage of TR8Q to arachidonate metabolism. The subsequent establishment of KYM·1·derived cell lines that 
display TNFR selective resistance further supports a segregation of TR60 and TR8Q signaling pathways for induc· 
tion of apoptotic cell death. Moreover, these results demonstrate an independent control of the distinct signaling 
cascades used by TR60 and TR80. This allows a highly flexible regulation of a cellular TNF response in those cases 
in which both receptors contribute to overall TNF responsiveness. The Journal of Immunology, 1994, 153: 1963, 
T NF is a pleiotrophic cytokine that is primarily pro--duced by activated macrophages. Originally named for its ability to induce tumor necrosis in 
certain model systems, TNF is now known to play a major 
role in many processes of inflammation affecting both he--
matopoietic and nonhemopoietic tissues. Beside a physi· 
ologic role of TNF in ontogeny and control of certain 
infections, TNF is also recognized as an important patho· 
genic factor in several chronic diseases (for reviews see 
Refs. 1, 2). This dual role of TNF in vivo is on the basis 
of the ability of TNF to modulate the expression of a va· 
riety of genes, including several other proinfiammatory cy· 
tokines such as If......l , If......6, granulocyte·macrophage CSF, 
cytokine receplors, adhesion molecules, and enzymes of 
various metabolic and catabolic pathways (reviewed in 
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Ref. 3). Furthermore, TNF has been demonstrated 10 pas· 
sess direct cytotoxic activity in vitro for certain tumor cells 
and for some nonnal cells (4-6). 
TNF and Iymphotoxin initiate their broad range of eel· 
lular responses by interaction with cell sudace membrane 
receptors. Two distinct but related receptor molecules 
have recently been molecularly cloned (7-10), here re· 
ferred to as TROO (type I) and TR80 (type 11). Both re· 
ceptors have significant homologies in their extracellular 
domains with repeat cysteine-rich sequences, defining 
them as members of a recently established growing recep· 
tor family (11). In contrast, the cytoplasmic domains of 
TR60 and TR80 are unrelated and give no indication by 
whlch mechanisms they are coupled to and activate intra-
cell ular signaling pathways, 
In addition to differences in primary structure. expres-
sion of the two TNFRs seems to be differentially regulated 
and shows lissue·spccific prevalence (1Z-14), Thus, al-
though C<rexpression of both receptors is found in many 
cells, there is typically a quantitative dominance of one of 
the two receptors. For example, lymphoid cells predomi· 
nantty express TR80 molecules, whereas epithelial cells 
typically express TR60 (15). 
Concerning the cytotoxic activity of TNF, recent find-
ings have drawn new attention to this particular action as 
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an important physiologic function. First. a role of TNF as 
a possible stimulating and effector molecule of NK/lym-
phokine-activatcd killer cells is apparent from several 
studies (16, 11). Second, TNF seems to function as a tranS-
ducer of cellular cytotoxicity in its membrane-integrated 
form, c.g., on macrophages (IS). Third. and most intriguing, 
recently, TNF has been proposed to act as an inducer of ap-
optotic ceU death during thymocyte maturation (6, 19). 
Qearly. 1NF has the polentialto exert cytotoxic effects for 
different cell types in differential ways, because it can induce 
both necrotic and apoptolic forms of cell death (20, 21). 
The cellular events in lNF-mediated cytotoxicity after 
ligand binding to membrane receptors are still poorly un-
derstood. Involvement of different signal transduction 
pathways has been suggested. These include activation of 
phospholipase (PL») A2 with release of arachidonate me-
laboliles (22. 23). Slimulalion of PLs D (24) and C (25.26) 
with activation of protein kinase C (PKC) by diacylglyc-
erols, activation of sphingomyelinase activity with subse-
quent release of ceramides (27), and, finally, hydroxyl rad-
ical production by mitochondrial enzymes (28). On the 
other hand, most tumor cell lines are sensitive to the cy-
totoxic action of TNF only in the presence of synergizing 
biologic or chemical reagents. This seems to be true inde-
pendent of the pattern of TNFR expression. Therefore, it is 
likely that intracellular regulatory circuits control the sen-
sitivity toward the cytotoxic action of TNF. For example, 
IL-l and TNF, itself, have been demonstrated to induce 
TNF resistance in a protein synthesis-dependent manner 
(29). Key molecules in induction of lNF resistance could 
represent manganese-dependent superoxide dismutase 
(30). heal shock proleins (31). and PKs (32. 33). 
Until recently the role of the two TNFRs for induction 
of cytotoxic effects of TNF was unclear. As of now, the 
vasl majority of cellular responses have been attributed 10 
signaIing via TR60, whereas only a few examples exist to 
demonstrate TRSO-initiated cellular answers. In particular, 
TNF-mediated cytotoxicity has been linked to TR60 in a 
number of different buman cell lines (12, 34). The princi-
pal capability of TR60 to trigger cytotoxicity on its own 
has been clearly demonstrated in heterologous human! 
mouse bioassays in which a selective cross-species acti· 
valion of the murine TR60, but not TR80, was achieved 
(35). Furthermore, studies with receptor subtypc-specific 
agonistic antisera have indicated that Abs specific for mu-
rine TR60 induce cytotoxicity. whereas otherwise agonis-
tic TR80-specific sera failed to do so (36). 
A recent report has attributed this capability of TR60 to 
a cytoplasmic region with homology to the apoptosis in-
ducing Ag FaslAPO·l, another member of the TNFR fam-
ily (31). Although these data suggest that TR60 plays a 
, Abbreviations u!ted in this p.;Iper: Pi. phospholipase; pc, phosphatidylcho-
line; Pie, protein kinase; ROI, radiul oxygen intennediate; BPB, brOfTlO-
phenKyl bromide; NCOC. 2·nilll>4-arboxyphl!nol N,N-<liphenylurbiilrmt~; 
NDGA, nordihydroguairefic. ac.id; TIFA, thenoyhrinUOf03c.etone; PleC. protein 
kina.5e C; PKA, protein kmase A. 
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major role for induction of a cytotoxic response, other 
studies indicate that TRaO may also be involved. Thus, in 
U937 cells, tbe blocking of each of the receptor subsets 
resulted in a significant reduction in lNF-induced cyto-
toxicity (38). Furthermore, it was shown that overexpres-
sion of TR80 in HeLa cells strongly enhanced TNF sen-
sitivity (39). An even more complicated situation might be 
found in thymocytes in which the pattern of cytotoxic re-
sponses to TNF could be controlled by both receptors in a 
very subtle way (6). 
Using the human rhabdomyosarcoma cell line KYM-l, 
which co-expresses high numbers of both receptors, we 
recently demonstrated that each receptor is able to induce 
cytotoxicity on its own (40). Moreover. limited receptor 
triggering that used the respective specific Abs indicated 
additive action (40). Here we show that, on cross-linking, 
each receptor induces apoptosis, as revealed from the in-
duction of DNA fragmentation and typical morphologic 
changes. To obtain additional infonnation about the signal 
transduction pathways involved, we used a number of se-
lective inhibitors to interfere with either TR6()... or TRSO-
induced apoptosis. Furthermore, we established JCYM-
I-derived cell clones showing receplor-type selective 
resistance. Both experimental approaches indicate clearly 
that the two TNFRs initially activate different signal path-
ways that eventually merge and lead 10 the identical cel-
lular response, i.e., apoptosis. 
Materials and Methods 
Cell lines and reagents 
The human rhabdomyosarcoma ceU line KYM-l (41) was generously 
supplied by Dr. M. Sekiguchi (tnstil\llC of Medical Sc:ic.na:, University of 
Tokyo, Tokyo, Japan). Cells wc.rccultured at3rC and 5% CO2 in Oitles 
RPMll64(1 medium (Biochrom. Berlin, Germany) conwning 10% beat-
inactivated FCS and antibiotics. The gtDCf81ion and specificity of the 
mAb H398, directed against TR60 (12), the rabbit anti·human TR80 
serum MOO (40), and the agonistic mAb htt·l (IS) has been described. To 
generatc rcsislallt KYM· I subc:loncs, cells were grown under culture coo· 
ditions in the presence of roc.asing concentrations of hlr-! for KYM· 
60res or MBO serum for KYM·8Qres cells. Human rTNF-a (sp. aa. 2 x 
10' U/mg) was kindly provided by Knoll AG, Ludwigsbafen, Ckrmany). 
The following reagents were purchased from Slgma Chemical Co. (Dei· 
senhofen, Germany); amyta1 (amobarbitat); antimycin; bromophcnacyl 
bromide (BPS): genistein; lithium chloride, 2-nitr0-4-carboxyphenyl 
N.N-diphenylcarbamate (NCDC): neomycin; nordihydroguaiatetic acid 
(NDGA); pargytine; quinacrine; and tbenoyltrifluoroaoelOnc (TrFA). 
H7, H8, H89, K·2S2a, K-252b, staurosporine, and calphostin C were 
from Calbiochem, Bad Sodc.n. Gennany. D609 was from Kamiya Bio-
medical Company. Thousand Oab, CA. For use in cytotoxicity assays, 
stock solutions of tbe inhibitors were prepared in medium, ethanol, or 
DMSO as appropriate, such that the final concentration never exceeded 
0.5%, which was conlIolled not to affect cell viability or TNF 
cytotoxicity. 
Electron microscopic histology 
Cell Cllltures were filed ill 2.5% g1utanldehyde (Merc.k, Darmstadt, Ger-
many) in 0.1 M PBS at pH 7.1 for that room temperature. Postfixation 
in 1 % osmium tetrolfide (Muck, Dannstadt. Germany) in 0.1 M PBS was 
followed by dehy~tion in ethanot (8 min in 40, SO, 60, 70, and 8()11, 
ethanol. 2 X IS min in 96 and 100% ethanol), and propytene oxide (2 X 
IS min). After impregnation overnight with 2;1 and 1:1 mixtures of pro-
pylene oxide and the epoxy rc.sin, respectively, cells wc.re embedded in 
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gelatin capsules and polymcriz.cd for 12 h at 4{j·C and at leas! 48 b at 
70·C. Specimens were thin sectiooed witb a diamood knife on a Reichert 
O~ U) ultramicrotome (Re~chert.Jung, NUOlocll, Germany), stained 
with uranyl acetate and lead Cllrate, and examined with a Zeiss EM lOA 
electron miCfOSC(Jpt al 60 kV. 
Detection of DNA fragmentation 
Cells.were inc.ubaled under cullure conditions with the indicated reagents 
for dl[ercnt limes, then harvested, and DNA was isolated by standard 
procedur~ DNA was. ~alyzcd b~ electrophoresis on a 1.2% agarose gel 
and visualized by elhiCfium bromide staining. 
Cytotoxicity assay 
This assay was conducted essentially as desaibed previously (5). Briefly, 
cells were seeded into 96-well microtiter plates al I X lit ce1lslw-ell and 
aUowed 10 grow overnight before lhe addition of the different subslances 
to a final volume of 200 ~. For inhibitor studies, the respcclive concen-
trations of lhe different substances nOI exhibiting more than 10% cyto-
loxic elrect. per se, over !be assay period were inilially determined. lbe 
5ubs/;ances were added 30 to 60 min before lNF or the raxptor.specific: 
agonists. Experiments Ihal used calphostin C as a specific PKC inhibitor 
were performed under iUumination (42). After 18 b of culture MIT. 
dimethylthiazol bromide (10 JLI/well of a S mg/ml solution in PBS) was 
added 10 all wells and metabolically active cclls were allowed 10 produce 
the formazan product for 2 h at 3rC. Subsequently, 90 ~ of a 15% SDS 
solution in 0.02 N Ha was added. 00s were read after an additional 4·b 
incubation at room lemperature at S60 om. 
Results 
Both TNFRs can independently mediate cytolysis in the 
human rhabdomyosarcoma cell line KYM-l (40). To ap-
proach the molecular mechanisms involved, we first in-
vestigated, by using eleclron microscopic analyses, Ihe ul-
trastructural changes preceding lNF-induced cell death in 
KYM-l cells. After stimulation wilh either TNF or the 
respective receptor-specific agonistic Abs, the typical on-
sel of apoptotic cell death was revealed in all cases (Fig. 
l). Accordingly, treatmenl wilh either TNF, Ihe TR60-spe-
cific mAb H39S plus a secondary cross-linking reagent 
(goat anti-mouse IgG), or the polyclonal TRBO-specific 
rabbit serum MSO (40) initiated strong vacuolization, con-
densation of chromatin at the nuclear membrane, and cel-
lular fragmentation. All of these morphologic criteria have 
been associated with programmed cell death (43). Addi-
tional support for the induction of apoptosis, rather than 
necrosis, comes from studies of DNA fragmentation 
caused by induction of an endonuclease(s) that preferen-
tially digests internucleosomal DNA (44). As shown in 
Figure 2, incubalion of KYM-I cells with TRSO-specific 
agonistic Abs resulted in a typical DNA degradation pat-
tern with approximately ISO-bp steps s imilar 10 the DNA 
ladder observed on TNF-treatment or TROO-specific stim-
ulation . Thus, independent and selective triggering of 
1NFRs in each case resulted in typical apoptotic cell 
death. 
Because TRSO, like TR60, is capable of conferring ap-
optotic signals to the cell nucleus. we next asked whether 
both receptors use idenlical intracellular s ignaling path-
ways. To determine this, we used several inhibitors of 
well-defined signal transduction pathways that have been 
1965 
implicated in TNF responses and asked whelher they 
would interfere with lNF-induced cytolysis of KYM-l 
cells. Initially, we tested a broad variety of kinase inhib-
itors for thcir ability to interfere with 1'NF-mediated cy-
totoxicity. Neither the potent tyrosine kinase inhibitor 
genistein nor the selective PKC inhibitor calphostin C 
showed Significant effects on TNF-induced cytotoxicity. In 
contrast, the isoquinoline sulfonamide H8 clearly antago-
nized with the cylotoxic effects of TNF (Fig. 3). Only par-
tial inhibition, however, was noted at the concentrations 
used. Higher concentrations of this PK inhibitor could nOI 
be used because of toxic s ide effects of the compound 
itself. Interesti ngly, the related compounds HS9 and H7 
did not significantly interfere with TNF cytotoxicity. In 
contrast, the highly potent serine/threonine and tyrosine 
PK inhibitor staurosporine, similar to the compounds 
K252a and K252b, strongly enhanced TNF-induced 
cytotoxicity (Fig. 3). 
Radical oxygen intermediates (ROIs) have been shown 
to be involved in lNF-induced cytotoxicity in different 
cellular systems (28, 45. 46). Therefore, we investigated 
several inhibilors of the mitochondrial electron transport 
system for interference with TNF-mediated cytotoxicity in 
KYM-l cells. Clearly, amy tal, a complex I inhibitor, ex-
erted protective effects, whereas lTFA, an inhibitor of 
complex II formation, was ineffective (Fig. 3). Antimycin 
A. a complex 1II inhibitor, which leads to the accumula-
tion of ROIs in the mitochondria (46), enhanced TNF cy-
tOloxicity. The laller data are in accordance with the pro-
posed role of oxygen radical generation as a causal 
mechanism of TNF cytotoxicity (28) in KYM-l cells. 
Regarding the other compounds tested, the Jipoxygen-
ase inhibitor, NDGA, the PL inhibitor, neomycin, and the 
inhibitor of monoamine oxidase. pargyline, all signifi-
cantly inhibited TNF-mediated cytotoxicity in KYM-l 
cells. However, in all cases only partial protection was 
observed at the highest possible (nontoxic) concentrations 
used (Fig. 3). These results are in agreement with reports 
demonstrating the involvement of Pl..Az and lipoxygenase 
metabolites in cell killing by TNF (23. 24). However. a 
number of additional PtAz inhibitors used, such as BPS, 
NCDC, or quinacrine, and the PC-PLC-specmc inhibitor 
D609 failed to protect KYM-l cells from lNF-mediated 
cytotoxicity, although thcy have been shown to interfere 
with TNF signaling in other cellular systems (22, 27). 
Some compounds that inlcrfcre with TNF action have been 
shown to be effective via modulation of TNFR expression 
(47, 48). To verify that the substances used here are indeed 
effective at a postreceptor, i.e., signal transduction level, bind-
ing competition studies with radiolabeled TNF and the re-
spective receptor-specific Abs were performed. These exper-
iments revealed that none of the 1NF response-inhibiting 
substances, Le., H8, neomycin, NDGA, pargyline, and 
amytal. significantly changed the expression of the two 
TNFRs or interfered with ligand or Ab binding to membrane 
expressed receplors (data not shown). 
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FI GU RE 1. Apoptosis of KYM-l cells induced via both TNFRs. Transmission electron micrographs were taken after 8 h of 
treatment of KYM-l cells with medium (A), 20 nglml TNF (B), I :200 dilution of TRBO-specific rabbit serum M80 (q, or 3 p.g/ml 
TR60-specific mAb H398 plus 10 p.glml goat anti-mouse IgG (0). Arrowheads indicate nuclear membrane without (Al or with 
condensed chromatin (8 through D). Ba rs " 5 }J.m . 
Cu rrently, all of the known TNF signal Iransduction 
pathways have been linked to TR60 rather than TR80 (27. 
49-5 1). Therefore. il was of great inleresl 10 determine 
whether the above inhibitors could be used \0 dist ingu ish 
between the signals used by the two dist inct TNFRs in 
KYM-I cells. Receptor-specific agonistic Abs were used 
to selective ly induce cytolysis in KYM- l ce ll s. In a first 
set of experiments, inhibitors were used at a cons tant sub-
toxic concentralion and the respective TNFR sti muli were 
titrated. The data oblll ined (Fig. 4) indeed revea l a differ-
ent ial sensitivity to the inhibitors and suggest a segrega-
tion in the signal pathways used by TR60 and T R80 for 
induct ion of apoptosis in KYM - l cells. Thus, TR60-trig-
gered cytotox icity could be antagonized by pargyline and 
H8 (Fig. 4, A and B). but nOt by NDGA (Fig. 4C). In 
contrast, the inhibitor NDGA specificall y interfered with 
TR80-l1lediated cyto lysis induced by a TR80-speciHc sc-
rum (Fig. 4G), but no inhibition cou ld be obwi ned with 
either H8 or pargyline (Fig. 4 , E and F). To ensure that the 
observed se lectiv ity of H8, pargyline , and NDGA WllS not 
concentrat ion dependent, we ti trated the inhib itors in a 
second set of experiments. Representative results are 
The Journal of Immunology 
. : : 
'\oO~ ••• 
FIGURE 2. Kinetics of DNA fragmentation on selective 
TNFR activation. KYM-l cells were treated as described in 
Figure I with TNF (A ), M80 serum (8 ), or H398 plus goal 
anti-mouse ISG (e) for the indicated times. Control lanes (cl 
represent 18-h stimulation with medium (/\ ), control rabbit 
seru m (8), or goa t anti-mouse ISG .110ne (C). DNA was ex-
tracted and subjected to electrophoresis on a 1.1% agarose 
gel in the presence of elhidium bromide. 
shown in Figure 5. which clearly demonstrates that 
the selectivity of the inhibilOrs was independent of 
the concentration used. Again, only p3rtia l protection 
could be obtained because of the intrinsic loxicity of these 
compou nds. 
Because ill KYM-l ce lls the selective activ3tion of each 
of the TNFRs finall y leads to the development of apopto-
sis. il seems likely th tH bolh s ignal pathways me rge at a 
point before the relevant intrilccllular effector molecules of 
apoptosis arc act ivated. Indeed. wc found that down-reg-
ulation of ROI formation by amy tal sign ificant ly amel io-
rated both TR60- and TRSO- induccd cylOlysis (Figs. 4. f) 
and H and 5D}. Taking into consideration that amy tal pos-
sesses a considerable intrinsic cytotoxici ty at the concen-
tralions used. TR60-triggered effects could be blocked ap-
proximately 30% (Fig. 4D: O.S J-Lg/ml H39S mAb) and 
T RSO-mediated effects were inhibited to a lesser. bUI sig-
nificant. extenl (20%: Fig. 4H: seru m dilution I :SOO). On 
Ihe basis of these resu lls wc conclude Ihat. in KYM -I 
ce lls_ the signal s induced by both receptors mighl be con-
nected to Ihe mi tochondrial ROI system. 
Wc howe recently shown that induct ion of TNF resis-
tance in KYM - I ce lls affects both TNFRs (52). Provided 
the s igll<lling cascades triggered by the twO TNFRs segre-
gate. it wou ld be possible to establish selectively resislant 
ce ll lines derived from KYM· 1 by prolonged specific st im-
ulation of on ly one of the two TNFRs. Indeed. after 2 to 4 
wk of cult ure in the presence of Ihe TR60-specific ago-
nistic mAb, h1 r- l . the surviving ce lls had become highly 
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resistant toward a subsequent cha llenge with the same 
stimulus (Fig. 6A). Remarkably. Ihe sensitivity of these 
cell lines, designated K YM-60res, toward MSO-induced 
apoptosis was only slight ly reduced (Fig. 68). The recip-
roca l resu lts were obtained uCier a se lectio n with MSO 
serum. In this case, a strong desensit izat ion o f TRSO sig-
naling (Fig. 68) hardly affected se nsitivity toward TR60-
induced cytotoxici ty (Fig. 6A). 
Next, wc wamed 10 know the effects of T R60 or TR SD 
desensitizat ion on the expression of TNFRs by ligand 
compclition studies with iodinated TNF and receptor spe-
cific Abs. As published previously (52), neither stimulus 
had any effects on TR60 cel l surface ex pression, whereas 
TNF or MSO treatment led 10 a reduction in TRSO receplor 
expression. When TRSD-resistam ce ll lines had been es-
tablished after approximate ly 14 days of continuous sti m-
ulation, these cells expressed 3000 to 6000 TRSO mo le-
cules/cell. On additional culture in the presence of TRSO 
agonists, this number furt her declined to levels below de-
tection « I00/cc lJ ) within 2 to 3 mo (52: and data not 
shown). However, induction of resislance in the KYM-
SOres cells shown in Figure 6 c:tOnot be attributed to ho-
mologous reeeptor down-regulation. because these cells still 
expressed 4000 TRSO molecules/cell (data not shown). l1lis 
suggCStS a postreccptor level of resislance induct ion prccced-
ing complete loss of membrane receptors. in contrast. KYM-
60rcs cells, having gained strong resistance toward TR60-
specific agonists (Fig. M), showed no change in either TR60 
or TRSO membrane expression. l1lese data indicate that the 
sensitivity changes in this subline arc strictly confined to a 
postreceptor level , i.e .. afrect s ignal transduction. 
Although the deve lopment o f selective receplor resis-
tance was reproducible in a number of independent exper-
iments. it was not possible to gener:lle ce ll lines with stable 
phenotypes. First. the KYM-60res line cou ld be revened 
readily to higher sensitiv ity within I wk after ,Ibrogat ion 
of the receptor-specific stimulus. Second. with a prolonged 
period (> 2 mol of constant selecti ve pressure, both cell 
lines. KYM-60res and KYM -SOres. converted 10 a cross-
resistant phe notype in which both TNFR signal pathways 
were lIffected (d'lliI not shown). 
Discussion 
TIle role of the two defined TNF membrane receplors is 
currelllly discussed in a controversial manner. In the ma-
jority of experimental systems. the abilit), of TNF to exe rt 
cytotox ic effects has been clearly attributed 10 TR60 (12. 
34, 36, 37). This investigat ion , however, unilmbiguously 
demonstrates that TR SD is per se able to trigger apoptosis, 
i.e., programmed cell death. TypiCll1 symptoms of apop+ 
tosis. like DNA fragmentation and chromatin condensa-
tion at the nuclear membrane. were noted on independent 
triggering of each of the two TNFRs (Figs. I and 2). A 
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FIGURE 3. Influence of various inhibitors of intracellular signal pathways on TNF-mediated cytotoxicity. KYM-l cells were 
cultured for 18 h in microtiter plates with or without 250 p&,ml TNF (approximately EDso) in the absence or presence of 
genistein (3.2 ~), Ha (15 pM), H89 (0.5 IJM), H7 (6 .3 pM), K-252a (250 nM), K-252b (2 .5 ~), staurosporine (25 nM), 
calphostin C (50 nM), neomycin (1 mM), NOGA (1 0 IJM), quinacrine (2.5 pM), NCOC (50 JLM), BPB (2.5 I'M) , 0609 (120 pM), 
liCl (2 .5 mM), pargyline (1 .25 mM), amytal (400 IJM), TIfA (45 pM), or antimycin (5 pM). The maximum concentration for 
each drug that did not, on its own, exhibit more than 10% cytotoxic effect over the assay period was determined and chosen 
for the experiments. Cell viability was determined by formazan production and evaluated in an EUSA reader at S60 nm. Shown 
is the influence of the drugs on TNF-induced cytotoxicity setting the TNF effect without the drug as 100% and the OD in the 
presence of the inhibitor alone as 0%. Experiments were performed in triplicate and the mean SO of at least three independent 
experiments is presented (signifi cance was evaluated by using Student's Hest:·p < 0.05; up < 0.01). 
minor difference observed was the slower kinetics of ap· 
oplotic development after stimulation ofTRSO when corn· 
pared with those of selective TR60 stimulation or of com-
bined receplor triggering. Significant DNA fragmentation 
could be detected after 4 h of stimulation with TNF. 
whereas 8 hand 12 to 18 h of TR60 and TR8D stimulation, 
respectively. were necessary 10 obtain comparable effects 
(Fig. 2). These differential kinetics in apoplotic develop-
ment, confirmed by visual microscopic controls. could ei· 
ther reflect differences in signal transduction pathways or 
be a rcsull of the different reccplor cross·linking efficien-
cies by the Abs vs TNF. In addition, because antagonistic 
Abs specific for each of the two receptors do inhibit TNF 
cytotoxicity in KYM· I cells (40). cooperative effects of 
TR60 and TR80 on TNF triggering are conceivable. 
Because KYM·l cells express extraordinarily high num-
bers ofTRSO compared with norma1tissucs the ability of this 
receplor to induce programmed cell death could be attributed 
to this fact and, consequently, could represent a specific prop-
erty of oruy this particular cell line. However, investigations 
performed with the myeloid granulocyte-macrophage CSF-
dependent cell line, GMSO (53), revealed that overexpres· 
sion of TRSO is not a prerequisite to function as an inducer of 
apoptosis. GMSO cells express TR80 at levels comparable 10 
primary cells (- 2000/cell) and also develop apoptosis on se-
iective stimulation of TRSO (S. 6z, manuscript in prepara· 
tion). Therefore, it seems conceivable that TRBO receptors 
could be involved in TNF-mediated apoptosis in biologically 
relevant situations. e.g., in negative selection of thymocytes. 
The recent work of Hemandez-Caselles and Stutman (6) is in 
accordance with this view. These authors suggested that 
TROO is involved in both growth stimulation and induClion of 
apoptosis by TNF. dependent on the culture conditions used. 
The availability of a cell line that shows an identical 
cellular response on selective stimulation of each of the 
two TNFRs prompted us to study identity or differences in 
the intracellular signals involved. In a first step, we tested 
a broad range of inhibitors of potential intracellular sig· 
naling molecules for their effects on TNF-induced apop-
tosis in KYM-l cells. From the emerging pattern of mod· 
ulalion of TNF responsiveness, the following conclusions 
can be drawn. A number of PKC inhibitors were found to 
act in an additive/synergistic way with TNF, suggesting 
that they either enhance TNF-mediated cytotoxicity di-
rectly or block concomitantly induced protection mecha-
nisms. These enhancing compounds include H7, slauros-
porine, and K252A and B, substances that have been often 
used as inhibitors of PKC. but certainly have a broader 
target spectrum (32, 54). On the olher hand, calphoslin C, 
currently regarded as a highly potent and specific inhibitor 
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FIGURE 4. Inhibition of receplor-specific induction of cy-
totoxicity. KYM-l cells were incubated with increasing con-
centrations of either TR60-specific mAb H398 plus 3 J..lg/ml 
goat anti-mouse rgG (A through U) or TRaO-specific rabbit 
serum (E Ihrough H) in the absence (O) or presence (.) of 
1.25 mM pargyl ine (A and E), 15 pM Ha (B and F), 10 J.!M 
NDCA (Cand G), orO.5 mM amylal (Dand H). Viability was 
determined as described in Figure 3, The maximum cytotoxic 
effect of the respective agonist under the given experimental 
conditions was 100% and the medium control, 00/0, i.e., the 
intrinsic cytotoxic effect of the respective inhibilor was not 
subtracted. A representative experiment is shown . 
of several PKC isoenzymes. did not affect TNF-triggered 
cytolysis (Fig. 3). These results question the role of cal-
phostin C-sensitive PKC isoenzymes in signaling of. and 
in protection from, TNF cytotoxicity in KYM-l cells (26, 
32), altbougb the role of serine/threonine-specific PKs in 
TNF signal transduction seems to be evident (2), 
Quite remarkable protective effects were found with an· 
other kinase inhibitor, the isoquinoline sulfonamide deriv-
ative H8. Although often used as a PKA-specific reagent, 
this inhibitor is now also known 10 affect various other 
kinases, depending on the concentration used (54). Morc· 
over, specific involvement of PKA in TNF signa ling 
seems unlikely because the related inhibitor H89 was to-
tally inefficient. This derivative has a very similar structure 
to H8 but has a higher affinity for cAMP-dependent ki-
nases (IC~ of 0.048 vs 0.48 p.M) and is, thus, expected to 
block PKA more effectively (55; and information of the 
supplier). Taken together, the data obtained with the PK 
inhibitors indicate a role of PKs in TNF signaling and 
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FIGURE 5. Dose-response c:urves of inhibitors, KYM-1 
cells were treated with serial dilution of inhibitors alone (0 ) 
or with 0.75 J..ls'ml H398 plus 3 ",glml goat anti·mouse IgG 
(0) or MBO serum (1 :1500; . ) in the presence of serial di-
luted inhibitors. Viability was determined as described in Fig-
ure 3. The maximum cytotoxic effect of the respective agonist 
under the given experimental conditions was 100% and the 
medium control. 0%. Representative experiments are shown. 
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FIGURE 6. Development of receptor-specific resistance in 
KYM-l-related cell lines. KYM-l cells had been cultured in 
the presence of increasing concentrations of TR60· (KYM-
60res cells) or TRao- (KYM-aOres cells) specific agonists. 
Typical sensitivity patterns after 3 wk of culture are displayed 
in comparison with untreated KYM· 1. Cells were washed ex-
tensively then stimulated with the TR60·specific mAb htr-1 
(A) or MaO serum (8) for la h, and viability was determined 
as described in Figure 3. The maximum cytotoxic e ffect of the 
respective agonist under the given experimental conditions 
was 100%. A representative experiment is shown. 
TNF-induced protective mechanisms but suggest that nei· 
ther conventional PKC sUbtypes nor PKA are critically 
involved in either process in KYM· t cells. 
Furthermore, the use of various inhibitors or phospho-
lipid metabolism suggested involvement of the PLA2"Ii· 
poxygenase pathway in TNF-mediated cytotoxicity, which 
is in full agreement with data obtained by other investi· 
gators (22-24). The experimental results obtained in this 
study, however, did not reveal exact components involved 
1970 
in this process because the PLAz inhibitors SPB and quin-
acrine, in contrast with neomycin and NDGA, were inef-
fective. Regardless of the precise location of inhibitory 
action, the identification of inhibitors that interfere with 
TNF-induced cytotoxicity in KYM-l enabled us to inves-
tigate whether TNFR signaling pathways segregate. In-
deed. some of the inhibitory compounds revealed a clear 
segregation in this regard. The HS-sensitive PKs that are 
involved in TNF-mediated cytotoxicity can be clearly 
linked 10 TR60-induced pathways (Fig. 4). On the other 
hand, NDGA, often used as an inhibitor of Iipoxygcnase 
pathway, but also known as an inhibitor of mono-oxyge-
nase and as a radical scavenger (56), selectively inhibited 
TRBO-mediated apoplosis (Fig. 4). Accordingly, lNF-me-
diated apoptosis in KYM-l cells can be initiated by both 
TNFRs using at least initially distinct signal pathways. 
These two pathways apparently function in an additive 
manner, as demonstrated previously (40), and most likely 
merge at some point upstream of mitochondrial ROI pro-
duction before the activation of the apoptotic effector mol. 
eculcs. This is suggested from data obtained with the ROI 
production inhibitor amy tal, which reduced cytotoxicity 
induced by both TROO and TR80 (Fig. 4), 
KYM-I cells have been shown to readily develop lNF 
resistance on prolonged treatment with TNF (52), The dif-
ferential sensitivity of TROO- and TR80-mediated apopto--
sis 10 various inhibitors of the signal transduction mecha-
nisms raised the possibilily 10 selectively induce resistance 
at a given receplor sUbtype. Cell lines developing such a 
receptor-specific resistance were, in fact, reproducibly ob-
tained and, thus, further support the view of a distinct sig-
nal transduction pathway usage of the two TNFRs. To-
gether, these data suggest that for both TNFRs response 
limiting steps in the respective signaling pathways must 
exist which 1) are distinct from each other and 2} can be 
regulated independently. On the other hand, a limited 
cross-desensitization was reproducibly found in all 60res 
?nd SOres cell lines (Fig. 6), indicaling that some overlap 
10 TROO and TR80 action must exist. This could be effec. 
live al the slage of generation of apoplotic effector mole-
cules and/or directly upstream at a late step in the intra-
cellular signal pathway thal is shared by both receplors. 
In the case of KYM-80res cells, an additional mecha-
nism mighl be involved in the devclopment of resistance 
because these cells reduced TR80 membrane receptor ex-
pression (52; data not shown). The importance of this 
gradual membrane receptor loss for generation of resis-
tance is unclear at present. For example, we noted that 
TNF resistance preeeeded complete loss of receptors, and 
~lIy resistanl lines were Oblained that still expressed sig-
mficant numbers of TR80 membrane receplors. Although 
the mechanism of receptor down-regulation has not been 
addr~sscd in this study, Ab-induced receptor shedding is 
poSSible, because TR80-spccific mRNA levels remained 
unchanged (data nOI shown), In any case, TR80 down-
INDUCTION Of APOPTOSIS VIA BOTH TNf RECEPTORS 
regulation is induced by TR80 activation, itself, and does 
1'101 represent cross-modulation triggered by TR60. 
Currently. the majority of TNF responses has been at-
tributed to TR60, whereas the overall contribution and in 
particular the separate functional role of TRSO in TNF sig-
naling was unknown. Nevertheless. in a number of di1ferent 
cellular systems, cooperative effects of TR60 and TRSO have 
been described, These include cytotoxic effects of lNF on 
U937 cens (38), stimulatory activity for T cells and thymo-
cytes (57), and enhancement of surface Ag expression in co-. 
Ion carcinoma cells (14). We could now show that TRSO is 
involved in lNF-medialed signaling and present evidence for 
the existence of receplor selective signal pathways. These 
pathways may lead to the same cellular response yet arc sub-
jected to largely independent cellular control mechanisms, 
This finding suggests that it might be possible to develop 
strategies that circumvent the usually rapid process of lNF 
desensitization, Accordingly, an alternative shorHerm Ireat-
ment with receptor.specific agonists could prevent a general 
TNF unresponsiveness and, therefore, could be superior to a 
treatment with the natural ligand that affects both receptors 
simultaneously. 
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